New Edge Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

New Edge Advisors, LLC

$11.2 Billion
Q1 2024

A detailed history of New Edge Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 4,108 shares of REGN stock, worth $4.03 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,108

Previous 4,725 13.06%

Holding current value

$4.03 Million

Previous $4.15 Million 4.72%

% of portfolio

0.04%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $556,959 - $612,896	-617 Reduced 13.06%	4,108 $3.95 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $1.69 Million - $1.92 Million	2,179 Added 85.59%	4,725 $4.15 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $711,146 - $867,167	-1,027 Reduced 28.74%	2,546 $2.1 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $985,642 - $1.17 Million	-1,408 Reduced 28.27%	3,573 $2.57 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $654,631 - $795,545	962 Added 23.94%	4,981 $4.09 Million

Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $1.28 Million - $1.39 Million	1,818 Added 82.6%	4,019 $2.9 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $551,011 - $695,347	960 Added 77.36%	2,201 $1.52 Million
Q2 2022 Aug 09, 2022	BUY	$548.35 - $738.84 $680,502 - $916,900	1,241 New	1,241 $733,000
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $903,392 - $1.06 Million	-1,518 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$543.48 - $670.97 $471,197 - $581,730	867 Added 133.18%	1,518 $959,000
Q3 2021 Oct 29, 2021	BUY	$574.03 - $680.96 $16,646 - $19,747	29 Added 4.66%	651 $394,000
Q2 2021 Jul 22, 2021	BUY	$472.8 - $558.54 $3,782 - $4,468	8 Added 1.3%	622 $347,000
Q1 2021 Apr 26, 2021	SELL	$446.73 - $548.2 $47,353 - $58,109	-106 Reduced 14.72%	614 $291,000
Q4 2020 Jan 27, 2021	SELL	$478.3 - $607.98 $10,522 - $13,375	-22 Reduced 2.96%	720 $348,000
Q3 2020 Nov 03, 2020	BUY	$544.75 - $658.21 $64,280 - $77,668	118 Added 18.91%	742 $415,000
Q2 2020 Jul 29, 2020	SELL	$493.32 - $643.92 $231,367 - $301,998	-469 Reduced 42.91%	624 $389,000
Q1 2020 May 04, 2020	BUY	$336.18 - $494.43 $159,013 - $233,865	473 Added 76.29%	1,093 $534,000
Q4 2019 Jan 31, 2020	BUY	$274.13 - $376.51 $169,960 - $233,436	620 New	620 $232,000
Q2 2019 Aug 05, 2019	SELL	$299.6 - $414.82 $147,702 - $204,506	-493 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $22.1 Million - $26.1 Million	-59,342 Reduced 99.18%	493 $202,000
Q1 2019 May 09, 2019	BUY	$372.08 - $439.57 $22.3 Million - $26.3 Million	59,835 New	59,835 $124,000
Q4 2018 Jan 29, 2019	SELL	$335.82 - $403.04 $396,939 - $476,393	-1,182 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$351.14 - $408.51 $415,047 - $482,858	1,182 New	1,182 $478,000
Q4 2017 Feb 08, 2018	SELL	$358.63 - $469.95 $177,163 - $232,155	-494 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $195,846 - $228,816	454 Added 1135.0%	494 $232,000
Q2 2017 Aug 16, 2017	BUY	N/A	40	40 $0

Others Institutions Holding REGN

# of Institutions

1,426

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $105B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Account

New Edge Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History